Completed PHASE2 INTERVENTIONAL NCT00206778

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

A Randomized Open-Label 6 Month Acute and Maintenance Trial of Lamotrigine vs. Standard of Care Sodium Valproate Monotherapy for Treatment of Mixed Mania.

Sponsor: Beth Israel Medical Center

Conditions Mixed Mania Bipolar Disorder

Interventions Lamotrigine Sodium Valproate

Updated 6 times since 2017 Last updated: Nov 24, 2010 Started: Jul 31, 2003 Primary completion: Jul 31, 2007 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Mixed Mania Bipolar Disorder and is currently completed. Beth Israel Medical Center leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Medical Center

Data source: Beth Israel Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States